That Diabetic Girl Blog
In addition, fluid and electrolyte abnormalities further exacerbate vulnerability to CHE
It helps regulate appetite and blood sugar by signalling the brain to feel satisfied, slowing stomach emptying, and supporting better metabolic control
A novel triple therapy, retatrutide, could continue the string of game-changing metabolic agents that began with semaglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist for type 2 diabetes and obesity, and continued with tirzepatide, a dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
With GLP-1 medications, the appetite can be reduced so much that people end up becoming malnourished, creating loss of muscle and bone, resulting in frailty and blood chemistry imbalances rather than vitality and strength